Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
Frick A, Åhs F, Appel L, Jonasson M, Wahlstedt K, Bani M, Merlo Pich E, Bettica P, Långström B, Lubberink M, Fredrikson M, Furmark T. Frick A, et al. Among authors: bettica p. Eur Neuropsychopharmacol. 2016 Nov;26(11):1775-1783. doi: 10.1016/j.euroneuro.2016.09.004. Epub 2016 Sep 15. Eur Neuropsychopharmacol. 2016. PMID: 27642077 Clinical Trial.
A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.
Furmark T, Appel L, Henningsson S, Ahs F, Faria V, Linnman C, Pissiota A, Frans O, Bani M, Bettica P, Pich EM, Jacobsson E, Wahlstedt K, Oreland L, Långström B, Eriksson E, Fredrikson M. Furmark T, et al. Among authors: bettica p. J Neurosci. 2008 Dec 3;28(49):13066-74. doi: 10.1523/JNEUROSCI.2534-08.2008. J Neurosci. 2008. PMID: 19052197 Free PMC article. Clinical Trial.
Association between amygdala reactivity and a dopamine transporter gene polymorphism.
Bergman O, Åhs F, Furmark T, Appel L, Linnman C, Faria V, Bani M, Pich EM, Bettica P, Henningsson S, Manuck SB, Ferrell RE, Nikolova YS, Hariri AR, Fredrikson M, Westberg L, Eriksson E. Bergman O, et al. Among authors: bettica p. Transl Psychiatry. 2014 Aug 5;4(8):e420. doi: 10.1038/tp.2014.50. Transl Psychiatry. 2014. PMID: 25093598 Free PMC article.
A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
Mathew SJ, Vythilingam M, Murrough JW, Zarate CA Jr, Feder A, Luckenbaugh DA, Kinkead B, Parides MK, Trist DG, Bani MS, Bettica PU, Ratti EM, Charney DS. Mathew SJ, et al. Eur Neuropsychopharmacol. 2011 Mar;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. Epub 2010 Dec 30. Eur Neuropsychopharmacol. 2011. PMID: 21194898 Free PMC article. Clinical Trial.
Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.
Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ. Bettica P, et al. Neuropsychopharmacology. 2012 Apr;37(5):1224-33. doi: 10.1038/npp.2011.310. Epub 2012 Jan 11. Neuropsychopharmacology. 2012. PMID: 22237311 Free PMC article. Clinical Trial.
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, Fava M. Ratti E, et al. Among authors: bettica p. J Psychopharmacol. 2013 May;27(5):424-34. doi: 10.1177/0269881113480990. Epub 2013 Mar 28. J Psychopharmacol. 2013. PMID: 23539641 Clinical Trial.
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.
Ratti E, Bellew K, Bettica P, Bryson H, Zamuner S, Archer G, Squassante L, Bye A, Trist D, Krishnan KR, Fernandes S. Ratti E, et al. Among authors: bettica p. J Clin Psychopharmacol. 2011 Dec;31(6):727-33. doi: 10.1097/JCP.0b013e31823608ca. J Clin Psychopharmacol. 2011. PMID: 22020354 Clinical Trial.
66 results